Evolva Holding SA was engaged in researching, developing, and commercializing high-quality ingredients with applications in flavour & fragrancies, health ingredients, health protection, and other sectors... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RERHX | 59.24 | 0.11 | +0.19% |
| American Funds Europacific Growth R5E | |||
| PCBKX | 10.93 | -0.04 | -0.36% |
| Victory Pioneer Balanced R6 | |||
| LVOOX | 18.89 | -0.07 | -0.37% |
| Lord Abbett Value Opportunities F3 | |||
| COMZX | 41.30 | -0.25 | -0.60% |
| DWS Digital Horizons Inst | |||
| IYCEX | 16.78 | -0.13 | -0.77% |
| Macquarie Core Equity Fund Class R | |||
A.I.dvisor indicates that over the last year, ELVAF has been loosely correlated with REPL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVAF jumps, then REPL could also see price increases.
| Ticker / NAME | Correlation To ELVAF | 1D Price Change % | ||
|---|---|---|---|---|
| ELVAF | 100% | N/A | ||
| REPL - ELVAF | 60% Loosely correlated | -4.68% | ||
| CLYYF - ELVAF | 47% Loosely correlated | N/A | ||
| IBIO - ELVAF | 39% Loosely correlated | +6.18% | ||
| GLABF - ELVAF | 34% Loosely correlated | N/A | ||
| NRSN - ELVAF | 24% Poorly correlated | +4.11% | ||
More | ||||